APOTEX FDA Wednesday, June 25, 1997 -0.50 Negative

FDA Approves Unknown Drug — APOTEX

Apotex has received FDA approval for NDA020710, expected to introduce significant competition to the blockbuster market upon its launch. The entry of this new generic indicates a major erosion of the brand-name manufacturer's market share and revenue streams.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed